The Correlation between the Use of the Proton Pump Inhibitor and the Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

<div>The Publication bias. (a) Funnel plot analysis of overall survival (OS). (b) Funnel plot analysis of progression-free survival (PFS). (c) Begg’s funnel plots for evaluating the publication bias of overall survival (OS). (d) Begg’s funnel plots for evaluating the publication bias of progression-free survival (PFS).</div>

Journal of Oncology

fig3

Figure 3

Figure 3: The Correlation between the Use of the Proton Pump Inhibitor and the Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer 

Figure 3 | The Correlation between the Use of the Proton Pump Inhibitor and the Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer 